Deprecated: Unparenthesized `a ? b : c ? d : e` is deprecated. Use either `(a ? b : c) ? d : e` or `a ? b : (c ? d : e)` in /home/institu2/public_html/bibliographie/ecrire/inc/utils.php on line 2576
Angiopoietins/*genetics Biological Markers Carcinoma Differential Humans In Situ Hybridization *Molecular Diagnostic Techniques Neoplasm Metastasis RNA Messenger/*analysis RNA Neoplasm/analysis Retrospective Studies Renal Cell/*diagnosis/pathology/secondary Diagnosis Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinoma BACKGROUND: We have previously shown that angiopoietin-like 4 (angptl4) mRNA, a hypoxia-inducible gene, is highly expressed in clear cell renal-cell carcinoma (ccRCC), the most common subtype of RCC for which no specific marker is available. We here investigated whether angptl4 mRNA 1) could be a useful diagnostic and/or prognostic marker of ccRCC in a large and comprehensive retrospective series, 2) induction is dependent on the VHL status of tumors. METHODOLOGY/PRINCIPAL FINDINGS: Using in situ hybridization, we report that angptl4 mRNA is expressed in 100% of both sporadic (n = 102) and inherited (n = 6) primary ccRCCs, without any statistical association with nuclear grade (p = 0.39), tumor size (p = 0.09), stage grouping (p = 0.17), progression-free survival (p = 0.94), and overall survival (p = 0.80). Angptl4 mRNA was also expressed in 26 (87%) of 30 secondary ccRCCs but neither in any other secondary RCCs (n = 7). In contrast, angptl4 mRNA was neither expressed in 94% non-ccRCC renal tumors (papillary RCCs (n = 46), chromophobe RCCs (n = 28), and oncocytomas (n = 9)), nor in non-renal clear cell carcinomas (n = 39). Angptl4 expression was also examined in tumors associated (n = 23) or not associated (n = 66) with VHL disease. 40 (98%) hemangioblastomas expressed angptl4 whereas all pheochromocytomas (n = 23) and pancreatic tumors (n = 25) were angptl4-negative, whatever their VHL status. CONCLUSIONS/SIGNIFICANCE: Angptl4 mRNA expression was highly associated with ccRCC (p = 1.5 10(-49), Chi square test) allowing to define its expression as a diagnosis marker for primary ccRCC. Moreover, angptl4 mRNA allows to discriminate the renal origin of metastases of clear-cell carcinomas arising from various organs. Finally, inactivation of VHL gene is neither necessary nor sufficient for angptl4 mRNA induction. e10421 Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinoma http://www.ncbi.nlm.nih.gov/pubmed/20454689 5 4 2010 PLoS One 1932-6203 (ELECTRONIC) 1932-6203 (LINKING) J.Verine J.Lehmann-Che H.Soliman J. P.Feugeas J. S.Vidal P. Mongiat-Artus S.Belhadj J.Philippe M.Lesage E.Wittmer S.Chanel A.Couvelard S.Ferlicot N. Rioux-Leclercq J. M.Vignaud A.Janin S.Germain